
Photo for representation only.
New Delhi: The Brazilian health regulator on Monday scrapped the approval application of Bharat Biotech’s Covaxin setting the stage for the termination of a multi-million dollar deal Bharat Biotech had with Brazil to seek Covaxin doses to the South American nation. The US $324 million deal was signed in February. TNS